
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for h... Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.02 | 0.854700854701 | 2.34 | 2.6899 | 2.3 | 8133 | 2.3704082 | CS |
4 | -0.62 | -20.8053691275 | 2.98 | 2.98 | 2.2101 | 20868 | 2.54885965 | CS |
12 | -0.7 | -22.8758169935 | 3.06 | 5 | 2.2101 | 30698 | 3.47059918 | CS |
26 | -0.69 | -22.6229508197 | 3.05 | 5.01 | 2.1501 | 28247 | 3.41121651 | CS |
52 | -4.33 | -64.7234678625 | 6.69 | 6.8 | 2.1501 | 18735 | 3.70766161 | CS |
156 | -33.84 | -93.4806629834 | 36.2 | 40.8 | 0.474 | 132822 | 16.63950423 | CS |
260 | -702.24 | -99.665058189 | 704.6 | 822.3 | 0.474 | 507495 | 107.13156363 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions